Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...

Genmab raised the full-year revenue and operating income guidance after strong Q2 results. Click here to find out why GMAB ...

TORONTO, ON / ACCESS Newswire / September 9, 2025 / Northern Superior Resources Inc. (“Northern Superior” or the “Company“) ...

Steven McKnight and Dirk Görlich received the Albert Lasker Basic Medical Research Award for their work on the role of ...

Lucy Shapiro received this year’s Lasker Special Achievement Award for her discovery of how bacteria use genetic circuits to ...

The study by Reed et al. provides fundamental findings and convincing evidence defining the topological changes that occur during tumorigenesis. The findings enhance the understanding of stable ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today provided ...

The company’s operating loss declined by 51% year-over-year, reflecting a laser focus on relentless execution and significant ...

CDKs control cell cycle progression and transcription, pathways commonly dysregulated in cancer. This study identifies a ...

Novel Model Integrating TME Composition with TLS Gene Signatures Predicts Meaningful Survival Differences in Checkpoint Inhibitor-Treated Patients Cellworks Group Inc., a leader in Personalized ...

NEW YORK CITY, NY / ACCESS Newswire / September 6, 2025 / New to The Street, one of the nation’s premier financial media platforms, today announced that Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP), a ...

EV adoption in Europe is accelerating at pace. According to SNE and MarkLines, Europe's EV penetration rate rose from 23% to ...